US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Rugby Diocto Syrup

Reason Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

The Harvard Drug Group D-1120-2017
Class II · Moderate risk Terminated

Rugby Diocto Liquid

Reason Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

The Harvard Drug Group D-1119-2017
Class II · Moderate risk Terminated

Famotidine USP 20 mg

Reason Failed Tablet/Capsule Specification: out of specification for tablet weight.

PD-Rx Pharmaceuticals, Inc. NDC 55289-765-30 D-1057-2017
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Presence of Particulate Matter; stainless steel

ICU Medical Inc NDC 0409-7983-09 D-1091-2017
Class II · Moderate risk Terminated

Hydromorphone Hydrochloride Injection

Reason Presence of Particulate Matter: Silicone oil

Hospira INC, Lake Forest NDC 0703-0113-01 D-1082-2017
Class II · Moderate risk Terminated

Famotidine Tablets USP

Reason Failed Tablet/Capsule Specification; out of specification for tablet weight

Teva Pharmaceuticals USA NDC 0172-5728-60 D-1056-2017
Class II · Moderate risk Terminated

Entecavir Tablets 0.5 mg

Reason Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.

Hetero USA Inc NDC 31722-833-30 D-1095-2017
Class II · Moderate risk Terminated

Magnesium Citrate Oral Solution

Reason Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.

Vi-Jon, Inc. NDC 50804-686-38 D-1054-2017
Class II · Moderate risk Terminated

Glycopyrrolate Injection Solution

Reason Lack of Sterility Assurance.

Cantrell Drug Company NDC 52533-028-45 D-1067-2017
Class II · Moderate risk Terminated

Glycopyrrolate Injection Solution

Reason Lack of Sterility Assurance.

Cantrell Drug Company NDC 52533-028-16 D-1066-2017
Class II · Moderate risk Terminated

Glycopyrrolate Injection Solution

Reason Lack of Sterility Assurance.

Cantrell Drug Company NDC 52533-028-15 D-1065-2017